With over $2B assets under management, Frazier Healthcare Partners is a leading provider of growth capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.
Novo Nordisk to acquire Calibrium LLC
Tachi Yamada, M.D., Former Head of GSK and Takeda R&D, Re-Joins Frazier Healthcare as Venture Partner
DSI Renal Reaches 100 Dialysis Clinics Milestone
ProNAi Therapeutics Announces Pricing of Initial Public Offering